Testing urine for drugs
1992

Testing Urine for Drugs

publication Evidence: moderate

Author Information

Author(s): D. Catlin, D. Cowan, M. Donike, D. Fraisse, H. Oftebro, S. Rendic

Primary Institution: University of California, Los Angeles

Conclusion

Urine testing for drugs is complex and requires careful consideration of various factors to ensure accurate results.

Supporting Evidence

  • Urinalysis testing programs have been implemented by various organizations to combat substance abuse.
  • The analysis of body fluids for drugs occurs in medical and penalty models, each with different implications.
  • Testing in the penalty model is more demanding than in the medical model due to the need for accurate identification of substances.
  • Confirmatory tests like GC-MS are essential for unambiguous identification of banned substances.

Takeaway

This study explains how urine tests are done to check for drugs, and why it's important to make sure the tests are accurate.

Methodology

The study discusses the methods of urine collection, testing, and analysis for banned substances, including the use of gas chromatography-mass spectrometry (GC-MS).

Potential Biases

Potential biases may arise from the pressure to produce positive results in penalty model testing environments.

Limitations

The study highlights the challenges in ensuring sample integrity and the complexities of drug metabolism that can affect test results.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication